Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
NCT06620172

CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia

Led by Zagazig University · Updated on 2024-11-12

60

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare the effectiveness and safety of CT-guided versus fluoroscopy-guided trigeminal ganglion radiofrequency thermocoagulation (TG-RFT) in treating idiopathic trigeminal neuralgia (TN) in adults aged 18 and older. The main questions it aims to answer are: * Does CT-guided TG-RFT provide better pain relief compared to fluoroscopy-guided TG-RFT? * What are the differences in medication consumption between the two methods? * What are the procedure-related adverse events for both methods? Investigators will compare CT-guided TG-RFT to fluoroscopy-guided TG-RFT to see if one method is superior in treating idiopathic TN. Participants will: * Undergo either CT-guided or fluoroscopy-guided TG-RFT procedure * Be monitored post-procedure and followed up at 1, 3, and 6 months for pain relief, medication consumption, and adverse events.

CONDITIONS

Official Title

CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 18 years
  • Diagnosed with idiopathic trigeminal neuralgia based on International Headache Society criteria
  • Facial pain for at least six months with a Numeric Rating Scale (NRS) score greater than 6 despite medical treatment
  • Able to provide informed consent
  • Willing to follow study procedures and attend follow-up visits
Not Eligible

You will not qualify if you...

  • Vascular compression of the trigeminal nerve detected by MRI or MRI angiography
  • Secondary causes such as multiple sclerosis
  • Trigeminal autonomic cephalalgias with autonomic symptoms
  • Dental or temporomandibular joint problems
  • Previous surgery or interventional procedures for trigeminal neuralgia
  • Coagulopathy or use of antiaggregants and anticoagulants
  • Presence of a cardiac pacemaker
  • Kidney or liver insufficiency
  • Psychiatric illness diagnosis
  • Malignancy
  • Infection at the injection site or systemic infection
  • Currently enrolled in another clinical trial that could affect study outcomes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zagazig University, Faculty of Medicine

Zagazig, Sharqia Province, Egypt, 44519

Actively Recruiting

Loading map...

Research Team

A

Ahmed A Bessar, M.D., PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here